Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GD2-CART01 by Bellicum Pharmaceuticals for Medulloblastoma: Likelihood of Approval
GD2-CART01 is under clinical development by Bellicum Pharmaceuticals and currently in Phase I for Medulloblastoma. According to GlobalData, Phase I...
GD2-CART01 by Bellicum Pharmaceuticals for Pediatric Diffuse Intrinsic Pontine Glioma: Likelihood of Approval
GD2-CART01 is under clinical development by Bellicum Pharmaceuticals and currently in Phase I for Pediatric Diffuse Intrinsic Pontine Glioma. According...
GD2-CART01 by Bellicum Pharmaceuticals for High-Grade Glioma: Likelihood of Approval
GD2-CART01 is under clinical development by Bellicum Pharmaceuticals and currently in Phase I for High-Grade Glioma. According to GlobalData, Phase...